WCM
OGN icon

Wallace Capital Management’s Organon & Co OGN Stock Holding History

Wallace Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,039
Closed -$149K – 80
2025
Q1 		$149K Sell
10,039
-221
-2% -$3.4K 0.02% 81
2024
Q4 		$153K Buy
+10,260
New +$167K 0.02% 78

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Wallace Capital Management's OGN Position: Q2 2025 in Review

Wallace Capital Management sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 10,039 shares — an estimated $149K sold.

Wallace Capital Management first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $153K in Q4 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Wallace Capital Management reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Wallace Capital Management sold 10,039 Organon & Co shares in Q2 2025, an estimated $149K.
  • Wallace Capital Management first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
  • Wallace Capital Management's Organon & Co position peaked at $153K in Q4 2024.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Wallace Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.